Search Results - "Anheim, Mathieu"

Managing Aminotransferase Elevations in Patients with Friedreich Ataxia Treated with Omaveloxolone: A Review and Expert Opinion on Use Considerations.

Authors: Perlman, Susan Anheim, Mathieu Boesch, Sylvia et al.

Source: Neurology & Therapy. Aug2025, Vol. 14 Issue 4, p1209-1227. 19p.

ADCY5‐Mosaic Variants: A Diagnosis Not to Be Missed.

Authors: Innocenti, Alice Roze, Emmanuel Riant, Florence et al.

Source: Movement Disorders Clinical Practice. Nov2025, Vol. 12 Issue 11, p1968-1971. 4p.

STARDEV Study: Neurodevelopmental Trajectory and Long‐Term Outcomes of Patients with Startle Disease/Hyperekplexia.

Authors: Pina, Diane Roubertie, Agathe Spitz, Marie‐Aude et al.

Source: Movement Disorders Clinical Practice. Sep2025, Vol. 12 Issue 9, p1367-1373. 7p.

Exploring the link between personality dimensions and non-motor fluctuations in Parkinson's disease.

Authors: Boussac, Mathilde Faggianelli, Florent Harroch, Estelle et al.

Source: Journal of Parkinson's Disease. Aug2025, Vol. 15 Issue 5, p1007-1018. 12p.

RRP12 Variants Are Associated With Autosomal Recessive Brain Calcifications.

Authors: Monfrini, Edoardo Rinchetti, Paola Anheim, Mathieu et al.

Source: Movement Disorders. Dec2025, Vol. 40 Issue 12, p2792-2803. 12p.

Therapeutic modalities of deferiprone in Parkinson's disease: SKY and EMBARK studies.

Authors: Devos, David Rascol, Olivier Meissner, Wassilios G et al.

Source: Journal of Parkinson's Disease. Feb2025, Vol. 15 Issue 1, p72-86. 15p.

Detection of ATXN2 Expansions in an Exome Dataset: An Underdiagnosed Cause of Parkinsonism.

Authors: Casse, Fanny Courtin, Thomas Tesson, Christelle et al.

Source: Movement Disorders Clinical Practice. Apr2023, Vol. 10 Issue 4, p664-669. 6p.

Evolution of Neuroimaging Findings in Severe COVID-19 Patients with Initial Neurological Impairment: An Observational Study.

Authors: Lersy, François Bund, Caroline Anheim, Mathieu et al.

Source: Viruses (1999-4915). May2022, Vol. 14 Issue 5, p949-949. 18p.

Missense Variants in the A Isoform of FGF13 as a Novel Cause of Paroxysmal Dyskinesia.

Authors: Mignot, Cyril Papathanasiou Terzi, Matthildi Athina Ravelli, Claudia et al.

Source: Movement Disorders. Jul2026, Vol. 41 Issue 7, p1884-1892. 9p.

Night‐Time Apomorphine Infusion: Who Are the Best Candidates?

Authors: Cochen De Cock, Valérie Dodet, Pauline Leu‐Semenescu, Smaranda et al.

Source: Movement Disorders Clinical Practice. Aug2023, Vol. 10 Issue 8, p1192-1197. 6p.

Psychiatric Disorders and Apathy in Mixed Movement Disorders Linked to ADCY5 (MxMD‐ADCY5).

Authors: Méneret, Aurélie Tarrano, Clément Ekmen, Asya et al.

Source: Movement Disorders. May2026, Vol. 41 Issue 5, p1310-1314. 5p.

Distinct Brain Drivers and Shared Cerebello–Cortical Input in ADCY5 and SGCE Hyperkinetic Movements.

Authors: Tarrano, Clément Galléa, Cécile Ekmen, Asya et al.

Source: Movement Disorders. Apr2026, p1. 13p. 4 Illustrations.

Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa‐Therapy in Parkinson's Disease: A Randomized, Placebo‐Controlled Study (PREMANDYSK).

Authors: Rascol, Olivier Ory‐Magne, Fabienne Meissner, Wassilios G. et al.

Source: Movement Disorders. Mar2026, Vol. 41 Issue 3, p729-740. 12p.

Coronavirus Disease 2019: Associated Multiple Organ Damage.

Authors: Collange, Olivier Tacquard, Charles Delabranche, Xavier et al.

Source: Open Forum Infectious Diseases. Jul2020, Vol. 7 Issue 7, p1-4. 4p.

Personality dimensions of patients can change during the course of parkinson's disease.

Authors: Boussac, Mathilde Arbus, Christophe Dupouy, Julia et al.

Source: PLoS ONE. 1/7/2021, Vol. 16 Issue 1, p1-11. 11p.

Fatigue in de novo Parkinson's Disease: Expanding the Neuropsychiatric Triad?

Authors: Béreau, Matthieu Castrioto, Anna Lhommée, Eugénie et al.

Source: Journal of Parkinson's Disease. 2022, Vol. 12 Issue 4, p1329-1337. 9p.

Biallelic loss-of-function variations in PRDX3 cause cerebellar ataxia.

Authors: Rebelo, Adriana P Eidhof, Ilse Cintra, Vivian P et al.

Source: Brain: A Journal of Neurology; May2021, Vol. 144 Issue 5, p1467-1481, 15p

Personality Related to Quality-of-Life Improvement After Deep Brain Stimulation in Parkinson's Disease (PSYCHO-STIM II).

Authors: Boussac, Mathilde Arbus, Christophe Klinger, Helene et al.

Source: Journal of Parkinson's Disease. 2022, Vol. 12 Issue 2, p699-711. 13p.

Apathy in Parkinson's Disease: Clinical Patterns and Neurobiological Basis.

Authors: Béreau, Matthieu Van Waes, Vincent Servant, Mathieu et al.

Source: Cells (2073-4409). Jun2023, Vol. 12 Issue 12, p1599. 22p.

MRI dedicated to the emergency department for diplopia or dizziness: a cost-effectiveness analysis.

Authors: Kepka, Sabrina Zarca, Kevin Lersy, François et al.

Source: European Radiology. Nov2022, Vol. 32 Issue 11, p7344-7353. 10p. 2 Diagrams, 4 Charts, 2 Graphs.

Subjects: Magnetic resonance imaging, Diplopia, Dizziness, Propensity score matching, Cost effectiveness